LONDON BROKER RATINGS: Berenberg raises Hikma Pharmaceuticals to ’buy’

Archived article

Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.

The following London-listed shares received analyst recommendations Tuesday morning and on Monday:

----------

FTSE 100

----------

Berenberg raises Hikma Pharmaceuticals to ’buy’ (hold) - price target 2,400 (2,100) pence

----------

Barclays cuts Prudential price target to 1,250 (1,380) pence - ’overweight’

----------

Barclays reinitiates Barratt Developments with ’overweight’ - price target 641 pence

----------

UBS raises Tesco price target to 400 (330) pence - ’buy’

----------

FTSE 250

----------

Barclays raises HGCapital Trust to ’overweight’ (equal weight) - price target 600 (496) pence

----------

Barclays cuts HarbourVest Global Private Equity to ’equal weight’ price target 3,020 pence

----------

Barclays raises Molten Ventures target to 475 (330) pence - ’equal weight’

----------

Jefferies raises Hunting price target to 530 (500) pence - ’buy’

----------

SMALL CAP

----------

Deutsche Bank raises Polar Capital price target to 570 (510) pence - ’hold’

----------

Deutsche Bank raises Ashtead Technology to ’buy’ (hold) - price target 860 (835) pence

----------

Barclays raises Oakley Capital Invest target to 660 (645) pence - ’overweight’

----------

Copyright 2024 Alliance News Ltd. All Rights Reserved.